| Literature DB >> 27143358 |
Lynn Glowczewski Bedard1, Raghuvar Dronamraju2, Jenny L Kerschner3, Gerald O Hunter4, Elizabeth DeVlieger Axley4, Asha K Boyd1, Brian D Strahl5, Amber L Mosley6.
Abstract
Using affinity purification MS approaches, we have identified a novel role for casein kinase II (CKII) in the modification of the polymerase associated factor complex (PAF-C). Our data indicate that the facilitates chromatin transcription complex (FACT) interacts with CKII and may facilitate PAF complex phosphorylation. Posttranslational modification analysis of affinity-isolated PAF-C shows extensive CKII phosphorylation of all five subunits of PAF-C, although CKII subunits were not detected as interacting partners. Consistent with this, recombinant CKII or FACT-associated CKII isolated from cells can phosphorylate PAF-C in vitro, whereas no intrinsic kinase activity was detected in PAF-C samples. Significantly, PAF-C purifications combined with stable isotope labeling in cells (SILAC) quantitation for PAF-C phosphorylation from wild-type and CKII temperature-sensitive strains (cka1Δ cka2-8) showed that PAF-C phosphorylation at consensus CKII sites is significantly reduced in cka1Δ cka2-8 strains. Consistent with a role of CKII in FACT and PAF-C function, we show that decreased CKII function in vivo results in decreased levels of histone H2B lysine 123 monoubiquitylation, a modification dependent on FACT and PAF-C. Taken together, our results define a coordinated role of CKII and FACT in the regulation of RNA polymerase II transcription through chromatin via phosphorylation of PAF-C.Entities:
Keywords: FACT; PAF-C; SILAC; casein kinase II; chromatin; histone modification; phosphorylation; quantitative proteomics; transcription; ubiquitylation (ubiquitination)
Mesh:
Substances:
Year: 2016 PMID: 27143358 PMCID: PMC4919428 DOI: 10.1074/jbc.M116.727735
Source DB: PubMed Journal: J Biol Chem ISSN: 0021-9258 Impact factor: 5.157